Agenus (NASDAQ:AGEN) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1.38) by 25.36 percent. This is a 66.12 percent increase over losses of $(3.04) per share from the same period last year. The company reported quarterly sales of $24.07 million which missed the analyst consensus estimate of $26.26 million by 8.34 percent. This is a 14.07 percent decrease over sales of $28.00 million the same period last year.